Jason P. Rhodes, Director: Dyne Therapeutics DYN Sell · Filed 06/30

Trade details

Type: Insider sale
Amount: $3,467,661.12
Shares · price: 162,954 sh · $21.28 a share
Held after: 4,579,456 sh
Stock: Dyne Therapeutics DYN
Person: Jason P. RhodesDirector
Trade date: 26/06/26
Filed: 26/06/30
Days to filing: 4 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 05/27~07/26

Jason P. Rhodes's recent trades

Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2.2M
102,969 sh
$2.2M
Filed 06/30
Traded 06/29
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.7M
81,903 sh
$1.7M
Filed 06/30
Traded 06/26
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.4M
64,411 sh
$1.4M
Filed 06/30
Traded 06/26
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1.1M
51,756 sh
$1.1M
Filed 06/30
Traded 06/29
Jason P. RhodesDirector
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$860.4K
40,702 sh
$860.4K
Filed 06/30
Traded 06/29